Table 3.

The mean concentrations of IL-1β, sIL-1RII, IL-1Ra, IL-6, sIL-6Rα, and sgp130 in the serum of control and patients with Lyme disease.

	Serum
	Control n = 30	Patients n = 43
	$\overline{x}$ ± SD	$\overline{x}$ ± SD
IL-1β (pg/mL)	3.7 ± 1.4	36 ± 10*
sIL-1RII (ng/mL)	4.1 ± 1.6	4.3 ± 1.2
IL-1Ra (ng/mL)	0.4 ± 0.1	0.8 ± 0.3*
IL-6 (pg/mL)	5.3 ± 0.9	12 ± 5.5*
sIL-6R (ng/mL)	14 ± 6.7	56 ± 5.1*
sgp130 (ng/mL)	37 ± 5.9	72 ± 8.1*
IL-15 (pg/mL)	290 ± 91	383 ± 101*

*Statistical differences between control and patients groups (P < .001).